Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Braz J Microbiol ; 53(2): 739-748, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35301695

RESUMO

Human sporotrichosis is caused by different Sporothrix species; however, Sporothrix brasiliensis is the main species, usually related to cat transmission in urban areas. A retrospective descriptive study was conducted at the Institute of Infectology Emílio Ribas from 2010 to 2018. Demography, clinical, diagnostic, and therapeutic data were obtained from medical records. Polymerase chain reaction of the calmodulin gene was performed to identify Sporothrix species. In addition, to evaluate the spread of the disease across São Paulo metropolitan region, TerraView version 4.2.2 software was used for geocoding cases according to residence addresses. Kernell's maps using QGIS software version 2.16.3 were constructed to determine the concentration of cases. Results: 260 cases of sporotrichosis were diagnosed between 2010 and 2018. We observed a 700% increment in the number of human cases in the 2016-2018 triennium compared with the 2013-2015 triennium. Female adults with a median age of 46 years old were the predominant infected group associated with cats' exposition at home care, although the age range of all patients was 01 to 86 years old. The main epidemiological risk of acquiring sporotrichosis was contact with cats, reported by 96.5% of the patients. Molecular identification showed that most of the tested isolates were Sporothrix brasiliensis. Lymphocutaneous form was observed in 59.2% and fixed cutaneous form in 37.5% of the patients. Regarding treatment, itraconazole was the main drug used (94.2%) with a cure rate of 98.8%. We observed an important spread of human sporotrichosis involving cat transmission caused by Sporothrix brasiliensis in a densely populated area of São Paulo state. These results are important to alert clinicians and dermatologists about the occurrence and progression of a neglected tropical disease in an urban area and the urgent necessity to include sporotrichosis as a differential diagnosis in the clinical investigation routine.


Assuntos
Doenças do Gato , Sporothrix , Esporotricose , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Brasil/epidemiologia , Doenças do Gato/tratamento farmacológico , Doenças do Gato/epidemiologia , Gatos , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Pessoa de Meia-Idade , Doenças Negligenciadas , Estudos Retrospectivos , Esporotricose/tratamento farmacológico , Esporotricose/epidemiologia , Esporotricose/microbiologia , Adulto Jovem
2.
BMC Mol Cell Biol ; 22(1): 55, 2021 Oct 29.
Artigo em Inglês | MEDLINE | ID: mdl-34715781

RESUMO

BACKGROUND: Psoriasis is a chronic inflammatory disease dependent upon a complex interaction between genetic predisposition and immunological factors. It is characterized by skin lesions throughout the body, causing great morbidity and affecting life quality. The present study aimed to evaluate the protein and mRNA expression of heparanase-1 (HPSE), heparanase-2 (HPSE2), syndecan-1 (SYND1), metalloproteinases (MMP2, MMP9), and tissue inhibitor metalloproteinases 2 (TIMP2) in skin samples. METHODS: From each psoriasis patient, two samples were collected, one sample from a psoriasis plaque (n = 23) and the other sample from non-affected skin (n = 23), as well as tissue collected by blepharoplasty from control individuals (n = 18). Protein expression was investigated by immunohistochemistry, followed by digital quantification. Quantitative RT-PCR obtained mRNA expression. Statistical analyses were done, and p values < 0.05 were considered significant. RESULTS: A significant increase in protein and mRNA expression was observed in both heparanases (HPSE and HPSE2), and higher protein levels of MMP9 and TIMP2 were observed in the psoriasis plaque compared to the non-affected skin. The data point to a probable activation of MMP2 by TIMP2. Moreover, there was a significant increase in HPSE2, SYND1, MMP9, and TIMP2 in non-affected skin samples from patients with psoriasis than in the control sample (tissue obtained by individuals who do not have psoriasis). CONCLUSIONS: These results show a possible correlation between the characteristic inflammatory process and alterations in the expression of the extracellular matrix in psoriasis. The increased expression of HPSE2, SYND1, MMP9, and TIMP2, even in the absence of psoriatic plaque, indicates that these molecules may be involved with extracellular matrix changes in the initial alterations the psoriatic process and may be candidates for the development of target treatments.


Assuntos
Psoríase , Matriz Extracelular/genética , Humanos , Imuno-Histoquímica , Psoríase/genética
3.
Rev Soc Bras Med Trop ; 54: e0514-2020, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33759920

RESUMO

A 31-year-old male patient developed an ulcer on the glans penis that evolved for three months without healing. We diagnosed it as leishmaniasis using polymerase chain reaction. No immunosuppression or associated diseases were observed. The patient was treated with meglumine antimoniate that cured the lesion in a month post-treatment. Here, we report this case of cutaneous leishmaniasis lesion at the unusual location of glans penis in an immunocompetent individual. The lesion likely developed due to the bite of a vector, highlighting the need for considering cutaneous leishmaniasis among differential diagnosis of sexually transmitted diseases in areas endemic for leishmaniasis.


Assuntos
Antiprotozoários , Leishmaniose Cutânea , Compostos Organometálicos , Adulto , Antiprotozoários/uso terapêutico , Brasil , Genitália , Humanos , Leishmaniose Cutânea/diagnóstico , Leishmaniose Cutânea/tratamento farmacológico , Masculino , Meglumina/uso terapêutico , Antimoniato de Meglumina/uso terapêutico , Compostos Organometálicos/uso terapêutico , Reação em Cadeia da Polimerase
4.
Rev Soc Bras Med Trop ; 51(1): 105-107, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29513829

RESUMO

Visceral leishmaniasis is common in Brazil and is caused by Leishmania (Leishmania) infantum/chagasi. Post-kala-azar dermal leishmaniasis frequently follows visceral leishmaniasis caused by L. donovani, and para-kala-azar dermal leishmaniasis refers to an uncommon presentation wherein it occurs simultaneously along with visceral leishmaniasis. While post-kala-azar dermal leishmaniasis only occurs occasionally in L. infantum/chagasi infections, it frequently occurs in patients with concomitant immunosuppression (HIV co-infection). Here, we describe the first case of para-kala-azar dermal leishmaniasis in Brazil. It is important to raise awareness of post- and para-kala-azar dermal leishmaniasis in L. infantum endemic areas as these patients may contribute to visceral leishmaniasis transmission.


Assuntos
Leishmaniose Cutânea/complicações , Leishmaniose Visceral/complicações , Adulto , Antiprotozoários/uso terapêutico , Humanos , Leishmaniose Cutânea/tratamento farmacológico , Leishmaniose Visceral/tratamento farmacológico , Masculino
5.
J Dermatolog Treat ; 29(8): 775-785, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29697004

RESUMO

PURPOSE: Data on chronic plaque psoriasis severity and its potential clinical and lifestyle implications in the Brazilian population are limited. The primary aim of this study was to assess the clinical severity of plaque psoriasis in Brazil. Further objectives included evaluating potential associations between disease severity and demographic, lifestyle, and clinical characteristics, health-related quality of life (HRQOL), and work productivity. MATERIALS AND METHODS: This observational (non-interventional) cross-sectional study was conducted in 26 dermatologic clinics across 11 Brazilian states. Psoriasis severity was assessed using investigator judgment and Finlay's Rule of Tens: a Psoriasis Area and Severity Index (PASI) score >10, a Body Surface Area (BSA) > 10%, or a Dermatology Life Quality Index (DLQI) score >10. RESULTS: Among 1125 patients, 205 (18.2%) had moderate-to-severe disease. On multiple regression analyses, psoriasis severity was significantly (directly) associated with the presence of physical inactivity and comorbid pain, anxiety, and depression; and significantly (inversely) associated with HRQOL and work productivity. LIMITATIONS: Cross-sectional studies cannot assess temporal trends, and observational studies cannot conclusively determine causality or exclude biases and confounding due to unmeasured variables. CONCLUSIONS: Among Brazilian patients with moderate-to-severe psoriasis, disease severity had far-reaching adverse impacts on lifestyle, comorbidities, HRQOL, and work productivity.


Assuntos
Psoríase/complicações , Psoríase/patologia , Adulto , Idoso , Instituições de Assistência Ambulatorial , Brasil , Estudos Transversais , Depressão/etiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Psoríase/psicologia , Qualidade de Vida , Análise de Regressão , Índice de Gravidade de Doença
6.
Rev. Soc. Bras. Med. Trop ; 54: e0514-2020, 2021. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1155581

RESUMO

Abstract A 31-year-old male patient developed an ulcer on the glans penis that evolved for three months without healing. We diagnosed it as leishmaniasis using polymerase chain reaction. No immunosuppression or associated diseases were observed. The patient was treated with meglumine antimoniate that cured the lesion in a month post-treatment. Here, we report this case of cutaneous leishmaniasis lesion at the unusual location of glans penis in an immunocompetent individual. The lesion likely developed due to the bite of a vector, highlighting the need for considering cutaneous leishmaniasis among differential diagnosis of sexually transmitted diseases in areas endemic for leishmaniasis.


Assuntos
Humanos , Masculino , Adulto , Compostos Organometálicos/uso terapêutico , Leishmaniose Cutânea/diagnóstico , Leishmaniose Cutânea/tratamento farmacológico , Antiprotozoários/uso terapêutico , Brasil , Reação em Cadeia da Polimerase , Antimoniato de Meglumina/uso terapêutico , Genitália , Meglumina/uso terapêutico
7.
São Paulo; s.n; 2004. [126] p.
Tese em Português | LILACS | ID: lil-419492

RESUMO

O presente estudo tem como objetivo definir o impacto da terapia antiretroviral combinada sobre a apresentação das dermatoses classicamente associadas à infecção pelo HIV-1, além de identificar novas condições clínico-dermatológicas decorrentes do prolongamento da sobrevida dos indivíduos. O estudo iniciou com três grupos que iniciaram tratamento para avaliar a eficácia da monoterapia com Indinavir ou Zidovudina ou da combinação de ambos os medicamentos. Em seguida todos os participantes do projeto, na fase aberta, eram tratados com medicação HAART. A candidose foi a dermatose que mais refletiu as transformações ocasionadas por influência da HAART, com redução de 40,3 por cento para 14,1 por cento após uso de HAART. O prurigo foi a dermatose mais freqüente , seguida de perto pela xerodermia, resultados compatíveis com o esperado efeito retinóide. O herpes zoster apresentado como dermatose prévia em 19,7 por cento, ao longo do estudo novos casos foram sendo observados, sendo que a maioria deles apresentava níveis de CD4+ entre 250 e 500 células/mm3 e carga viral < 50 cópias/ml. Estes dados podem inferir u ma melhora das condições imunológicas ou possivelmente ao processo de reconstituição imune. Os aumento dos quadros de farmacodermia podem estar associados ao advento de combinações multi-drogas ou reações de hipersensibilidade. Os casos de herpes simples e papilomavirose não se alteraram após o uso de HAART, talvez por não ter tido tempo hábil de não serem influenciados pela mudança da resposta imunológica. A terapêutica com inibidor de protease não impediu o aparecimento de sarcoma de Kaposi, porém não houve progressão das lesões. As alterações mais comuns associados ao uso de HAART foram: queilite descamativa, xerodermia, alopecia, encravamento das unhas e paroníquia. Estudos posteriores devem dar ênfase, além de alterações associados ao uso de novos antiretrovirais nas manifestações cutâneas, não há suficiente informação sobre o papel da reconstituição imunológica nos portadores de HIV-1


Assuntos
Síndrome da Imunodeficiência Adquirida , Terapia Antirretroviral de Alta Atividade , Dermatologia , HIV
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA